Skip to main content
TipRanks
Go Ultimate75% OFF

Daniel Gedeon Teper Insider Profile

11 Followers

Daniel Gedeon Teper, former CEO, Director, Ten Percent Owner at Immune Pharmaceuticals, holds 4.81M shares in Immune Pharmaceuticals (Ticker: IMNPQ). Most recently, Daniel Gedeon Teper Bought 937,500 shares of Immune Pharmaceuticals on Aug 04, 2016 for an estimated value of $356.25K.

Daniel Gedeon Teper's Trading History

IMNPQ
Immune Pharmaceuticals
Aug 04, 2016―Informative Buy356.25K$48.11K
IMNPQ
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Aug 04, 2016Informative Buy$356.25K937,500$0.38-76.50%
Jan 26, 2016Uninformative Buy$24.78K42,000$0.59―
Jan 19, 2016Uninformative Buy$24.75K44,200$0.56―
Jan 12, 2016Uninformative Buy$24.43K39,400$0.62―
Jan 06, 2016Uninformative Buy$49.60K62,000$0.80―

You May Also Like

Daniel Gedeon Teper insider profile FAQ

What is the percentage of profitable transactions made by Daniel Gedeon Teper?
The percentage of profitable transactions made by Daniel Gedeon Teper is 0%.
What is the average return per transaction made by Daniel Gedeon Teper?
The average return per transaction made by Daniel Gedeon Teper is -74.80%.
What stocks does Daniel Gedeon Teper hold?
Daniel Gedeon Teper holds: IMNPQ stocks.
What was Daniel Gedeon Teper’s latest transaction?
Daniel Gedeon Teper’s latest transaction was an Informative Buy of $356.25K.
What was Daniel Gedeon Teper's most profitable transaction?
Daniel Gedeon Teper’s most profitable transaction was an Informative Buy of IMNPQ stock on September 1, 2015. The return on the trade was -72.50%.
What is Daniel Gedeon Teper's role in Immune Pharmaceuticals?
Daniel Gedeon Teper's role in Immune Pharmaceuticals is CEO, Director, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.